Studies conducted on pancreatic cancer cell lines and cancer-associated fibroblasts (CAFs) have shown that increased HSPB6 expression in CAFs may contribute to the modulation of the tumor stroma. The gene discussed is HSPB6; the disease is familial pancreatic carcinoma.